http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2015034000-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
filingDate 2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-WO2015034000-A1
titleOfInvention Immunoglobulin binding domain multimers
abstract PROBLEM TO BE SOLVED: To provide an immunoglobulin-binding protein multimer having improved properties as an affinity ligand for affinity chromatography and an insoluble carrier obtained by immobilizing the multimer. Solution: An immunoglobulin binding domain (R2) containing an amino acid residue that is covalently bound to a carrier by an immobilization reaction on an insoluble carrier, and obtained by an immobilization reaction compared to the case where it does not exist due to the presence in the sequence. It consists of an immunoglobulin binding domain (R1) that does not contain an amino acid residue that reduces the immunoglobulin binding activity of the carrier, and has the following general formula: (R1) n- (R2) m or (R2) m- (R1) n (1) n is an integer of 5 or more and 9 or less, (2) m is an integer of 1 or 2, and (3) n (R1) domains may be the same sequence as each other. An immunoglobulin binding protein that satisfies the following conditions: (4) the total number of domains (n + m) is 6 to 10.
priorityDate 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008266219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008266221-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012133349-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456438065
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415753100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID125175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520307
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449812109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562155

Total number of triples: 40.